Flex Pharma: 2Q Earnings Snapshot
BOSTON (AP) _ Flex Pharma Inc. (FLKS) on Wednesday reported a loss of $9.1 million in its second quarter.
The Boston-based company said it had a loss of 50 cents per share.
The biotech drug developer posted revenue of $246,000 in the period.
The company’s shares closed at 83 cents. A year ago, they were trading at $4.25.